Department of Clinical Medicine, Division of Clinical Immunology and Allergy, Sapienza University, Rome, Italy.
Clin Immunol. 2010 Oct;137(1):122-33. doi: 10.1016/j.clim.2010.06.004. Epub 2010 Jun 26.
We investigated in systemic sclerosis (SSc) patients the T cell homeostasis and its relationship with the clinical course of the disease. Distribution of peripheral T cell subsets, thymic output, lymphocyte proliferation and apoptosis were analyzed by flow cytometry or ELISA. Age inappropriate levels of naive CD4(+) T cells and thymic output were observed. Proliferation of CD4(+) T cells, lymphocyte apoptosis and CD4(+) regulatory T (Treg) cell frequency were significantly higher than those observed in controls and significantly correlated with clinical phenotypes and clinical progression parameters i.e., diffusing capacity of the lung for carbon monoxide (DLCO) and disease activity. These data indicate that the evaluation of the T cell homeostasis can represent a valuable prognostic tool for SSc patients and it is useful to distinguish between limited and diffuse phenotypes. A therapeutic intervention targeted at reversing T cell homeostasis abnormalities would therefore potentially be helpful in counteracting disease progression.
我们研究了系统性硬化症(SSc)患者的 T 细胞稳态及其与疾病临床过程的关系。通过流式细胞术或 ELISA 分析外周 T 细胞亚群、胸腺输出、淋巴细胞增殖和凋亡。观察到幼稚 CD4(+) T 细胞和胸腺输出的年龄不当水平。CD4(+) T 细胞的增殖、淋巴细胞凋亡和 CD4(+)调节性 T(Treg)细胞频率明显高于对照组,并且与临床表型和临床进展参数(即一氧化碳弥散量(DLCO)和疾病活动度)明显相关。这些数据表明,T 细胞稳态的评估可以作为 SSc 患者有价值的预后工具,有助于区分局限性和弥漫性表型。针对逆转 T 细胞稳态异常的治疗干预可能有助于对抗疾病进展。